Evidence map›Paper›PMID 31547247›Full record

ArticleJournal of clinical medicine2019

Significance of the Glasgow Prognostic Score in Predicting the Postoperative Outcome of Patients with Stage III Gastric Cancer.

Shun-Wen Hsueh, Keng-Hao Liu, Chia-Yen Hung, Yung-Chia Kuo, Chun-Yi Tsai, Jun-Te Hsu, Yu-Shin Hung, Ngan-Ming Tsang, Wen-Chi Chou

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shun-Wen HsuehDepartment of Hematology-Oncology, Chang Gung Memorial Hospital at Keelung, Keelung 204, Taiwan.
Keng-Hao LiuCollege of Medicine, Chang Gung University, Taoyaun 333, Taiwan.
Chia-Yen HungDepartment of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan.
Yung-Chia KuoCollege of Medicine, Chang Gung University, Taoyaun 333, Taiwan.
Chun-Yi TsaiCollege of Medicine, Chang Gung University, Taoyaun 333, Taiwan.
Jun-Te HsuCollege of Medicine, Chang Gung University, Taoyaun 333, Taiwan.
Yu-Shin HungCollege of Medicine, Chang Gung University, Taoyaun 333, Taiwan.
Ngan-Ming TsangCollege of Medicine, Chang Gung University, Taoyaun 333, Taiwan.
Wen-Chi ChouCollege of Medicine, Chang Gung University, Taoyaun 333, Taiwan. wenchi3992@yahoo.com.tw.ORCID 0000-0002-0361-4548
Chang Gung University · TWMackay Memorial Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed at investigating the ability of a preoperative Glasgow prognostic score (GPS) to predict postoperative complications and survival outcomes in patients with stage III gastric cancer undergoing D2 gastrectomy. We retrospectively reviewed data from 272 such patients, treated between 2010 and 2016, at a Taiwanese medical center. The patients were categorized according to their GPS. In total, 36.8%, 48.5%, and 14.7% of the patients were assigned to groups with a GPS of 0, 1, and 2, respectively. Overall surgical complication rates in these groups were 30%, 45.5%, and 52.5% (

Indexed as

complicationgastrectomygastric cancerGlasgow prognostic scoresurvival

Identifiers

PMID31547247
PMCPMC6780196
OpenAlexW2972330182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.